đź“‹ FDA Reference

CrossFAST Integrated Microcatheter Advanced Delivery System

Vantis Vascular, Inc.

Contact a rep Compare similar devices

Summary: The CrossFAST Integrated Microcatheter Advanced Delivery System is a catheter-based delivery system used to access selected blood vessels and deliver therapeutic materials during minimally invasive vascular procedures. It is manufactured by Vantis Vascular, Inc. and cleared by the FDA through the 510(k) pathway as a Class II percutaneous catheter.

FDA Clearance Information

Pathway ? 510(k)
Number ? K262817 ↗
Decision Date ? September 18, 2026
Product Code ? DQY Catheter, Percutaneous
Device Class ? Class 2
Evidence ? 0 studies

FDA-Cleared Indications

  • For percutaneous introduction into blood vessels for the delivery of diagnostic or therapeutic agents and materials, consistent with the labeling for this catheter category.
  • Use is limited to trained clinicians and the specific device instructions for use, including stated vessel size, access route, and compatibility requirements.

Clinical Applications

  • Selective or superselective catheterization of blood vessels during image-guided endovascular procedures.
  • Delivery of embolic materials to selected arteries when used according to the device labeling and the embolic agent's instructions.
  • Delivery of therapeutic agents or other approved materials during vascular interventions.
  • Catheter-based vascular procedures performed by interventional radiology, neurointerventional, vascular, or other appropriately trained specialists.

Practical Considerations

  • The available catheter sizes, working length, distal configuration, and compatible guidewire or delivery materials should be confirmed in the current instructions for use.
  • The system is intended for use through a compatible vascular access sheath or guide catheter under fluoroscopic or other appropriate imaging guidance.
  • Potential contraindications and warnings include inability to safely access the target vessel, severe vessel spasm or tortuosity, thrombosis, dissection, perforation, infection, contrast allergy, and bleeding risk.
  • MRI safety depends on the exact device configuration and labeling. Do not assume the system is MR Safe or MR Conditional without checking the current manufacturer instructions.
  • Risks are related to both catheterization and the material or treatment delivered, including bleeding, hematoma, embolization to an unintended vessel, ischemia, infection, vessel injury, and contrast-related complications.

Procedures that use this device

Frequently Asked Questions

What is the CrossFAST Integrated Microcatheter Advanced Delivery System used for?

It is a percutaneous microcatheter system used to selectively access blood vessels and deliver diagnostic or therapeutic materials during image-guided vascular procedures. The exact permitted use depends on the current FDA clearance and manufacturer instructions for use.

What sizes does the CrossFAST microcatheter come in?

Available catheter diameters, lengths, distal tips, and compatibility specifications should be confirmed in the current Vantis Vascular product documentation. These details may vary by model and configuration.

Is the CrossFAST catheter MRI safe?

MRI safety cannot be determined from the device name alone. Check the current instructions for use and device labeling for the specific model before an MRI examination.

How long does the CrossFAST catheter last?

The system is generally a single-use device and is not intended for long-term implantation. Its duration in the body depends on the procedure and it is normally removed after the intervention.

How much does the CrossFAST Integrated Microcatheter cost?

The purchase price is not usually publicly listed and varies by hospital, distributor, contract, and configuration. Patient charges depend on the complete procedure, facility, physician, insurance coverage, and any deductible or coinsurance.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 The IR Device Brief

One email a month: new FDA clearances, recalls and device pages in vascular & interventional radiology.

We'll email you a link to confirm. Unsubscribe any time.

Suggest edits

For manufacturers and their teams. Each field shows what the page says now: add, remove or rewrite anything, and leave the rest as is. LA Vascular reviews every change before it goes live.

About you